Scinai Immunotherapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $282 | $0 | $0 | $0 |
Gross Profit | -657 | -157 | -84 | -144 |
EBITDA | -1,401 | -1,772 | -1,739 | -1,957 |
EBIT | -1,896 | -1,928 | -1,823 | -2,102 |
Net Income | -2,313 | -2,159 | -2,330 | 3,107 |
Net Change In Cash | 282 | 0 | 0 | 0 |
Free Cash Flow | -1,760 | -1,465 | -1,459 | -2,242 |
Cash | 3,214 | 4,826 | 4,870 | 6,362 |
Basic Shares | 837 | 506 | 300 | 469 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -512 | |||
EBITDA | -9,202 | -10,499 | -10,426 | 11,167 |
EBIT | -9,716 | -11,061 | -11,202 | 3,341 |
Net Income | -6,507 | -5,796 | -12,847 | -4,451 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,019 | -8,101 | -8,006 | -252,750 |
Cash | 4,870 | 14,075 | 17,365 | 9,412 |
Basic Shares | 390 | 188 | 141 | 110 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$4.30 |
2024-03-31 | -$0.47 |
2023-12-31 | -$4.70 |
2023-09-30 | $0.80 |
